Science Suggests That Spicer Is Wrong

In a White House press briefing, press secretary, Sean Spicer, suggested that legalized recreational marijuana would contribute to the nation’s opioid crisis. At this time, research suggests that opioid addiction is directly linked to excessive and improper prescriptions.

Read Full Article

NFL Players’ Association Calls Trump Offsides

Despite the recreational cannabis warning from Sean Spicer on 2/23, the NFL Players’ Association will continue is push to request “less punitive” cannabis policy for players.  The association says that this is a collective bargaining agreement issue and not a law enforcement one.

Read Full Article

California Is Cannabis Country

When you think wine country, you think California. But you may soon associate California with cannabis country. New reports show that Cali’s marijuana harvest is seven times more valuable than the state’s wine grape harvest. Vineyards may be swapping crops to follow the dollars.

Read Full Article

Poof! Cannabis Claims Disappear From DEA Website

As of February 13th, a document disseminating “misinformation” about cannabis was removed from the U.S. Drug Enforcement Administration’s website. “The DEA’s removal of these popular myths about cannabis from their website could mean the end of the Washington gridlock,” said Steph Sherer, executive director of Americans for Safe Access. Will the DEA make it reappear?

Read Full Article

Join The Big Boys, Aphria

Aphria Inc. (APH) has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX. APH must meet certain standards and customary conditions required by the TSX before the imposed 5/3/17 deadline. “Graduating to the TSX represents yet another important milestone for Aphria as we continue our successful journey as one of Canada’s leading cannabis companies,” Vic Neufeld, CEO of Aphria Inc.

Read Full Article

GWPH Q1 2017 Losses Less Than Expected

Canna-pharma giant, GW Pharmaceuticals, posted a Q1 2017 loss of $2.54 million. This is an improvement from the same period in 2016 where the company announced a $4.53 million loss. GWPH is banking on their lead cannabinoid product, Epidiolex. The company is also planning to introduce a candidate for autism spectrum disorders, which could be very exciting for the company.

Read Full Article

Canopy Growth Corp Closes its Acquisition of Metrum Health

A couple quick updates on one our favorite Canadian cannabis stocks. Canopy Growth Corp (TSX: WEED) now has a new ticker – changing to WEED from CGC. This is merely a cosmetic change. Shareholders don’t need to do anything. Secondly, Canopy has closed its acquisition of Metrum Health. The combined entity is the largest medical cannabis company in Canada. Shares of Metrum will no longer trade – shareholders will receive .7132 shares of Canopy per share of Metrum.

Read Full Article

GrowGeneration Expanding in High-Growth Colorado Market

GrowGeneration (OTC: GRWG) is a major supplier of retail and industrial hydroponic and organic gardening equipment. It operates in some of the fastest growing cannabis markets in the U.S. For example, it already owns and operates 8 stores in Colorado. GrowGen announced it is adding a 12the store, and its second in Denver – a 13,000 square foot facility that will also serve as the company’s new corporate headquarters. The location is killer –  more than 100 commercial growers operate in the same zip code. Keep your eye on GrowGen – this is a company I will be watching closely.

Read Full Article

Move over Boston Beer Company! AmeriCann (ACAN) is taking over.

AmeriCann, a Denver-based medical cannabis facility developer, has acquired a 53-acre property in Freetown, Massachusetts, formerly owned by brewing giant, Boston Beer Company (SAM). The property will be home to a 130,000 sqft cultivation and processing facility, as well as a 30,000 sqft research and development building.

Read Full Article